Philip James Wealth Mangement, LLC Biogen Inc. Transaction History
Philip James Wealth Mangement, LLC
- $857 Billion
- Q3 2025
A detailed history of Philip James Wealth Mangement, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Philip James Wealth Mangement, LLC holds 2,146 shares of BIIB stock, worth $320,462. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,146Holding current value
$320,462% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,045Shares Held
132MCall Options Held
2.84MPut Options Held
2.54M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.58 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.36 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.17 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.12 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$717 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...